|
Get Financial Filings and Annual Reports for Companies featured on TWST from EasyReports.net
TWST: Would you begin with an introduction to Cygnus?
Mr. Hodgman: We develop new and unique technologies for diabetes
monitoring, glucose monitoring in particular. We have developed a
new series of products that are breakthrough technologies, the
first and only approved FDA-approved glucose monitor that
provides frequent, automatic and non-invasive glucose monitoring. TWST: Could you elaborate on how the product actually works?
Mr. Hodgman: The device is a small monitor that looks like a
sports watch. It sits on the wrist or forearm area and uses a
small amount of energy that sends a force through the skin and
then draws from the skin interstitial fluid, which contains
glucose. As the glucose comes across the skin, it enters into
some glucose pads ' what we call the AutoSensors ' on the back of
the watch and creates a chemical reaction, sending out an
electrical signal, which we then measure. We calculate the
glucose reading through a series of proprietary algorithms and
then we report and store that on the device. You can set high and
low alerts so the watch will frequently (every 10 minutes) give a
reading and let you know where your glucose level is throughout
the day or night.
Tickers included in this excerpt: CYGN
For more information call (212) 952 7400. The
Wall Street Transcript does not endorse any of the comments made by interviewees, and does
not make stock recommendations.
|
|
 |
